Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Alcohol Use Disorder
NCT04141501Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Jun 2020
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Psilocybin with Placebo (2 arms). Primary endpoints: Changes in Time-Line Follow-Back at 6 months and Relapse using Time-Line Follow-Back at 4 weeks. Started Jun 2020; status: completed.
02
Drugs
psilocybin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04141501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04141501.